Phase-separated Nucleocapsid Protein of SARS-CoV-2 Suppresses Cgas-Dna Recognition by Disrupting Cgas-G3bp1 Complex

Sihui Cai,Chenqiu Zhang,Zhen Zhuang,Shengnan Zhang,Ling Ma,Shuai Yang,Tao Zhou,Zheyu Wang,Weihong Xie,Shouheng Jin,Jincun Zhao,Xiangdong Guan,Jianfeng Wu,Jun Cui,Yaoxing Wu
DOI: https://doi.org/10.1038/s41392-023-01420-9
IF: 39.3
2023-01-01
Signal Transduction and Targeted Therapy
Abstract:Currently, the incidence and fatality rate of SARS-CoV-2 remain continually high worldwide. COVID-19 patients infected with SARS-CoV-2 exhibited decreased type I interferon (IFN-I) signal, along with limited activation of antiviral immune responses as well as enhanced viral infectivity. Dramatic progresses have been made in revealing the multiple strategies employed by SARS-CoV-2 in impairing canonical RNA sensing pathways. However, it remains to be determined about the SARS-CoV-2 antagonism of cGAS-mediated activation of IFN responses during infection. In the current study, we figure out that SARS-CoV-2 infection leads to the accumulation of released mitochondria DNA (mtDNA), which in turn triggers cGAS to activate IFN-I signaling. As countermeasures, SARS-CoV-2 nucleocapsid (N) protein restricts the DNA recognition capacity of cGAS to impair cGAS-induced IFN-I signaling. Mechanically, N protein disrupts the assembly of cGAS with its co-factor G3BP1 by undergoing DNA-induced liquid-liquid phase separation (LLPS), subsequently impairs the double-strand DNA (dsDNA) detection ability of cGAS. Taken together, our findings unravel a novel antagonistic strategy by which SARS-CoV-2 reduces DNA-triggered IFN-I pathway through interfering with cGAS-DNA phase separation.
What problem does this paper attempt to address?